Global and Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 17-Nov-2021
No. of pages: 120
Inquire Before Buying

Global Chemotheraphy-induced Nausea and Vomitting Treatment Scope and Market Size

Chemotheraphy-induced Nausea and Vomitting Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotheraphy-induced Nausea and Vomitting Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Aloxi (Palonosetron)

- Kytril (Granisetron)

- Emend (Aprepitant)

- Others

Segment by Application

- Acute Nausea and Vomitting Treatment

- Delayed Nausea and Vomitting Treatment

- Anticipatory Nausea and Vomitting Treatment

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GlaxoSmithKline

- Helsinn

- Heron Therapeutics

- Merck & Co

- Tesaro

- Acacia Pharma

- Aphios

- Barr Laboratories

- Baxter Healthcare

- Eisai

- Especificos Stendhal

- F.Hoffmann La Roche

- Mundipharma

- Mylan Pharmaceuticals

- OPKO Health

- Orchid Healthcare

Global and Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aloxi (Palonosetron)
1.2.3 Kytril (Granisetron)
1.2.4 Emend (Aprepitant)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Nausea and Vomitting Treatment
1.3.3 Delayed Nausea and Vomitting Treatment
1.3.4 Anticipatory Nausea and Vomitting Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Perspective (2016-2027)
2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Growth Trends by Regions
2.2.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Dynamic
2.3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
2.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
2.3.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
2.3.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue
3.1.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue (2016-2021)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue
3.4 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio
3.4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2020
3.5 Chemotheraphy-induced Nausea and Vomitting Treatment Key Players Head office and Area Served
3.6 Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
3.7 Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Type
4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2022-2027)
5 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Application
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2016-2027)
6.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
6.2.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
6.2.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027)
6.2.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2027)
6.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
6.3.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
6.3.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027)
6.3.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2027)
6.4 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
6.4.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021)
6.4.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2016-2027)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
7.2.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2027)
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
7.3.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2027)
7.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
7.4.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
8.2.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
8.3.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region
8.4.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2016-2027)
9.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
9.2.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2027)
9.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
9.3.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2027)
9.4 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
9.4.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type
10.2.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application
10.3.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country
10.4.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Helsinn
11.2.1 Helsinn Company Details
11.2.2 Helsinn Business Overview
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.2.4 Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.2.5 Helsinn Recent Development
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Details
11.3.2 Heron Therapeutics Business Overview
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.3.4 Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.3.5 Heron Therapeutics Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.4.4 Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.4.5 Merck & Co Recent Development
11.5 Tesaro
11.5.1 Tesaro Company Details
11.5.2 Tesaro Business Overview
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.5.4 Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.5.5 Tesaro Recent Development
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Details
11.6.2 Acacia Pharma Business Overview
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.6.4 Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.6.5 Acacia Pharma Recent Development
11.7 Aphios
11.7.1 Aphios Company Details
11.7.2 Aphios Business Overview
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.7.4 Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.7.5 Aphios Recent Development
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Details
11.8.2 Barr Laboratories Business Overview
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.8.4 Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.8.5 Barr Laboratories Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.9.5 Baxter Healthcare Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.10.4 Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.10.5 Eisai Recent Development
11.11 Especificos Stendhal
11.11.1 Especificos Stendhal Company Details
11.11.2 Especificos Stendhal Business Overview
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.11.4 Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.11.5 Especificos Stendhal Recent Development
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Details
11.12.2 F.Hoffmann La Roche Business Overview
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.12.4 F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.12.5 F.Hoffmann La Roche Recent Development
11.13 Mundipharma
11.13.1 Mundipharma Company Details
11.13.2 Mundipharma Business Overview
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.13.4 Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.13.5 Mundipharma Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 OPKO Health
11.15.1 OPKO Health Company Details
11.15.2 OPKO Health Business Overview
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.15.4 OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.15.5 OPKO Health Recent Development
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Details
11.16.2 Orchid Healthcare Business Overview
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.16.4 Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021)
11.16.5 Orchid Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aloxi (Palonosetron)
Table 3. Key Players of Kytril (Granisetron)
Table 4. Key Players of Emend (Aprepitant)
Table 5. Key Players of Others
Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Regions (2016-2021)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Regions (2022-2027)
Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
Table 15. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players (2016-2021)
Table 18. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2020)
Table 19. Ranking of Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
Table 23. Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 66. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Helsinn Company Details
Table 69. Helsinn Business Overview
Table 70. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 71. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 72. Helsinn Recent Development
Table 73. Heron Therapeutics Company Details
Table 74. Heron Therapeutics Business Overview
Table 75. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 76. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 77. Heron Therapeutics Recent Development
Table 78. Merck & Co Company Details
Table 79. Merck & Co Business Overview
Table 80. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 81. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 82. Merck & Co Recent Development
Table 83. Tesaro Company Details
Table 84. Tesaro Business Overview
Table 85. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 86. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 87. Tesaro Recent Development
Table 88. Acacia Pharma Company Details
Table 89. Acacia Pharma Business Overview
Table 90. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 91. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 92. Acacia Pharma Recent Development
Table 93. Aphios Company Details
Table 94. Aphios Business Overview
Table 95. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 96. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 97. Aphios Recent Development
Table 98. Barr Laboratories Company Details
Table 99. Barr Laboratories Business Overview
Table 100. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 101. Barr Laboratories Recent Development
Table 102. Baxter Healthcare Company Details
Table 103. Baxter Healthcare Business Overview
Table 104. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 105. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 106. Baxter Healthcare Recent Development
Table 107. Eisai Company Details
Table 108. Eisai Business Overview
Table 109. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 110. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 111. Eisai Recent Development
Table 112. Especificos Stendhal Company Details
Table 113. Especificos Stendhal Business Overview
Table 114. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 115. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 116. Especificos Stendhal Recent Development
Table 117. F.Hoffmann La Roche Company Details
Table 118. F.Hoffmann La Roche Business Overview
Table 119. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 120. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 121. F.Hoffmann La Roche Recent Development
Table 122. Mundipharma Company Details
Table 123. Mundipharma Business Overview
Table 124. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 125. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 126. Mundipharma Recent Development
Table 127. Mylan Pharmaceuticals Company Details
Table 128. Mylan Pharmaceuticals Business Overview
Table 129. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 130. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 131. Mylan Pharmaceuticals Recent Development
Table 132. OPKO Health Company Details
Table 133. OPKO Health Business Overview
Table 134. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 135. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 136. OPKO Health Recent Development
Table 137. Orchid Healthcare Company Details
Table 138. Orchid Healthcare Business Overview
Table 139. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 140. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2016-2021) & (US$ Million)
Table 141. Orchid Healthcare Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2020 VS 2027
Figure 2. Aloxi (Palonosetron) Features
Figure 3. Kytril (Granisetron) Features
Figure 4. Emend (Aprepitant) Features
Figure 5. Others Features
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2020 VS 2027
Figure 7. Acute Nausea and Vomitting Treatment Case Studies
Figure 8. Delayed Nausea and Vomitting Treatment Case Studies
Figure 9. Anticipatory Nausea and Vomitting Treatment Case Studies
Figure 10. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 11. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Regions (2022-2027)
Figure 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2020
Figure 16. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2020
Figure 18. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type (2016-2027)
Figure 22. North America Chemotheraphy-induced Nausea and Vomitting Treatmen
  • 2021-2030 Report on Global Corneal Edema Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 105
    This report studies the Corneal Edema Drugs market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospital & Clinic, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bausch + Lomb, Abbott, Clear Eyes, Sager Pharma, ALCON, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Corneal Ed......
  • 2021-2030 Report on Global Veterinary Antifungal Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 121
    This report studies the Veterinary Antifungal Drugs market, covering market size for segment by type (Oral, Parenteral, etc.), by application (Livestocks, Companion Animals, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Veterinary An......
  • 2021-2030 Report on Global Corneal Edema Treatment Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 107
    This report studies the Corneal Edema Treatment market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospital & Clinic, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bausch + Lomb, Abbott, Clear Eyes, Sager Pharma, ALCON, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Cornea......
  • 2021-2030 Report on Global Antifungal Drugs for Veterinary Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 118
    This report studies the Antifungal Drugs for Veterinary market, covering market size for segment by type (Oral, Parenteral, etc.), by application (Livestocks, Companion Animals, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Antifunga......
  • 2021-2030 Report on Global Precision Medicine Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 135
    This report studies the Precision Medicine market, covering market size for segment by type (Drug Discovery, Biomarker-Based Test, etc.), by application (Cancer/Oncology, Central Nervous System (CNS), etc.), by sales channel (Direct Channel, Distribution Channel), by player (Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical ana......
  • 2021-2030 Report on Global OTC Hair Loss Treatments Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 121
    This report studies the OTC Hair Loss Treatments market, covering market size for segment by type (Minoxidil, Procapil, etc.), by application (Men, Women, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Johnson & Johnson, Taisho Pharma, Cipla, Bayer, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for OTC Hair Loss Treatments from ......
  • 2021-2030 Report on Global Advanced Drug Delivery Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 136
    This report studies the Advanced Drug Delivery market, covering market size for segment by type (Oral, Inhalation, etc.), by application (Hospitals, Diagnostic Centers, etc.), by sales channel (Direct Channel, Distribution Channel), by player (3M, Abbott Laboratories, Allergan, Antares Pharma, Baxter International, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market fo......
  • 2021-2030 Report on Global Advanced Drug Delivery System Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 130
    This report studies the Advanced Drug Delivery System market, covering market size for segment by type (Oral, Inhalation, etc.), by application (Hospitals, Diagnostic Centers, etc.), by sales channel (Direct Channel, Distribution Channel), by player (3M, Abbott Laboratories, Allergan, Antares Pharma, Baxter International, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global ma......
  • 2021-2030 Report on Global Biopharmaceutical CMO & CRO Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Jan-2022        Price: US 2500 Onwards        Pages: 133
    This report studies the Biopharmaceutical CMO & CRO market, covering market size for segment by type (Contract Manufacturing, Contract Research, etc.), by application (Biologics, Biosimilars, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Boehringer Ingelheim, Lonza, Inno Biologics, Rentschler Biotechnologie, JRS PHARMA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed histo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs